Change you board name to night shade, 'cause you're full of

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks Shady #62705
182
Change you board name to night shade, 'cause you're full of it.

Fauci didn't say that, you've been had.....again.

But hey, print out your post and present it in the next store visit when you're called out for not wearing a mask.


https://www.snopes.com/fact-check/fauci-blame...aths-1918/

Another Facebook user wrote: “Dr. Fauci saying masks should be mandated. Even though in 2008 he wrote a paper saying the MAJORITY OF THE PEOPLE THAY DIED IN THE 1918 SPANISH FLU DIED FROM SECONDARY BACTERIAL PNEUMONIA AS A DIRECT RESULT OF THE USE OF FACE MASKS.”

Fauci did not blame mask use for any deaths that occurred during the 1918 Spanish flu. In fact, the paper mentioned in the above-displayed Facebook posts doesn’t even mention masks.

In October 2008, Fauci co-authored a paper published in The Journal of Infectious Diseases about the role that bacterial pneumonia played during the 1918 flu pandemic (commonly referred to by the misnomer “Spanish flu”). An estimated 50 million people died during the 1918 flu pandemic, with approximately 675,000 of those deaths taking place in the United States. The paper co-authored by Fauci in 2008 found that these deaths weren’t caused by the flu alone, but that the majority “likely resulted directly from secondary bacterial pneumonia.”

Fauci said in a contemporary news release:

“The weight of evidence we examined from both historical and modern analyses of the 1918 influenza pandemic favors a scenario in which viral damage followed by bacterial pneumonia led to the vast majority of deaths … In essence, the virus landed the first blow while bacteria delivered the knockout punch.”

While some social media users presented this study as a cautionary tale against mask use — incorrectly claiming that it was the masks that were responsible for the development of bacteria — Fauci’s paper actually highlighted the need to stockpile antibiotics and bacterial vaccines as well as antiviral drugs and influenza vaccines in order to properly combat a pandemic.

Another excerpt from this news release explained:

The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Instead, most victims succumbed to bacterial pneumonia following influenza virus infection.

The pneumonia was caused when bacteria that normally inhabit the nose and throat invaded the lungs along a pathway created when the virus destroyed the cells that line the bronchial tubes and lungs.

A future influenza pandemic may unfold in a similar manner, say the NIAID authors, whose paper in the Oct. 1 issue of The Journal of Infectious Diseases is now available online. Therefore, the authors conclude, comprehensive pandemic preparations should include not only efforts to produce new or improved influenza vaccines and antiviral drugs but also provisions to stockpile antibiotics and bacterial vaccines as well.

In other words, this paper did not blame mask use for causing these bacterial infections. That connection — that mask use is actually dangerous because it causes bacterial infections — was made by social media users and is one that has been repeatedly shot down by experts.

In June 2020, The Associated Press investigated the false claim that mask use leads to bacterial pneumonia. Davidson Hamer, infectious disease specialist and professor of global health and medicine at Boston University, said at the time:



“There’s no evidence of masks leading to fungal or bacterial infections of the upper airway or the lower airway as in pneumonia.”
[…]
There’s no evidence that wearing face masks cause any harm besides some discomfort, Hamer said. However, he added paper masks that become visibly wet should be discarded.
[…]
“It’s so highly unlikely with normal mask use. There’s a real danger at spreading incorrect information like this, especially at a time when we really need to be encouraging more people to wear masks.”

Reuters spoke with the global team of health experts at LeanAboutCovid19.com, and were told that there was “no evidence” that regular mask use increased the risk of developing any “bacterial, fungal or viral infection in the lung.”

A statement from LeanAboutCovid19.com reads:


“In fact, according to a study published in the Preventive Medicine journal, wearing face masks is shown to protect people against bacterial infections in hospital settings, where health care workers are most prone to antibiotic-resistant  bacteria.”

Doctors at Lawrence Memorial Hospital in Lawrence, Kansas, also addressed this claim in an article debunking common mask myths. While one doctor noted that it was important to clean masks to prevent bacterial build-up, both noted that regular mask use does not lead to bacterial, fungal, or viral infections.


Am I breathing in more bacteria or virus if I wear a mask?
Dr. Brychel: If utilized and cared for properly, no. However, it is important that you either clean or exchange your mask at least once a day because masks can accumulate environmental particles, including virus, bacteria and fungi.

Dr. Penn: No. There is no evidence that masks lead to bacterial, fungal or viral infections of the upper or lower airway. However, masks that become soiled should be replaced and masks should not be worn for more than one day before laundering (if cloth) or replacing.

In short: In 2008, Fauci co-authored a report stating that the majority of deaths during the 1918 flu pandemic “likely resulted directly from secondary bacterial pneumonia.” This paper did not state that this secondary bacterial pneumonia had been caused by mask use. In addition to the fact that this study doesn’t mention or deal with masks, a multitude of experts have since dismissed the notion that masks increase the risk of bacterial infections.

By Dan Evon ,
Published 26 October 2020

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Qingdao's Food Trade Triumph at SIAL Paris Booms

Updated Category News Views 3

Qingdao Impresses in the Global Food Arena Well, 2026 is serving up something special from Qingdao. During SIAL Paris, everyone's talking about how Qingdao’s food companies smashed expectations with 82 million yuan in intended orders. You’ve got CCPIT Qingdao pulling the strings, setting up an exhibition platform that was nothing short of top-tier. Staging a Show at...

Continue Reading
Electrolux Trends: Q3 '26 Shows Resilience Amid Challenges

Updated Category News Views 3

Electrolux's Strategic Moves In A Tough Market Electrolux's Q3 2026 paints a gritty picture—yet there's a pulse of resilience underneath the numbers. Net sales bumped up to SEK 33,919m due to a 3.5% organic growth, showing the company's ability to swim through choppy waters. But let's not brush aside the sharp rocks they’re dodging: soaring raw materials and logistics...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 2

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
Innventure Faces Chaotic Legal Storm Over DarkNX Scandal

Updated Category News Views 1

Innventure's DarkNX Project: From Boon to Bane The stock market is no stranger to seismic shifts, but Innventure, Inc.'s recent plunge is a testament to the catastrophic impact missteps can unleash. This whole DarkNX debacle feels more like a meticulous car wreck than a business evolution. Unpacking the Allegations Sitting comfortably under the NASDAQ:INV ticker,...

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 1

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading
ImmunoForge Sets Sights on BIO-Europe 2026 for New Deals

Updated Category News Views 3

Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...

Continue Reading
Greenberg Traurig Eyes Accolades in Middle East Awards

Updated Category News Views 3

Greenberg Traurig Aims for Middle Eastern Legal Dominance Ah, the legal world, where firms jostle like bulls in a market for the prestige of an award—it's not just about the courtroom victories, but also about snatching the right titles at glossy ceremonies. On the docket this time: Greenberg Traurig has its sights set on several prime accolades at the Law Middle East...

Continue Reading
California Contractors Honored for Safety Commitment

Updated Category News Views 9

Commitment to Safety in the Construction Industry When it comes to construction, safety isn’t an afterthought—it’s woven into the very fabric of every project. The 39th Annual Construction Safety Excellence Awards by the Associated General Contractors of California (AGC of California) pits a spotlight on those embodying this ethos. Industry Leaders in Safety Held on...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 0

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading

Top 5 Most Recently Viewed Articles

RPA Market Set to Surge with Digital Transformation Support

Updated Category News Views 218

Understanding the Growth of the Robotic Process Automation Market The Robotic Process Automation (RPA) market is experiencing remarkable growth, with forecasts indicating an increase from USD 2.8 billion in 2023 to a staggering USD 38.4 billion by 2032. This impressive growth, at a compound annual growth rate (CAGR) of 33.8% from 2024 to 2032, reflects the growing...

Continue Reading
Unlocking Hidden Gems: Two Undervalued China Stocks to Buy

Updated Category News Views 246

Discovering Hidden Opportunities in China's Stock Market As the Chinese stock market experiences a renewed rally, discerning investors are on the lookout for undervalued companies with promising growth prospects. In a landscape dominated by major players like Alibaba and Tencent, two lesser-known stocks are gaining attention: Futu Holdings (NASDAQ: FUTU) and Atour...

Continue Reading
Exploring the Rise of Medical Spas: A Booming Industry

Updated Category News Views 186

Introduction to the Medical Spa Industry The medical spa industry is experiencing an exciting evolution, reflecting a shift in consumer preferences towards services that combine traditional spa ambiance with the expertise of medical professionals. With an increasing focus on aesthetic wellness and anti-aging solutions, we are witnessing an impressive market growth...

Continue Reading
Coherent Corp. Launches Chameleon Discovery LX Laser for Researchers

Updated Category News Views 189

Coherent Corp. Launches an Innovative Femtosecond Laser Coherent Corp. (NYSE: COHR), a renowned leader in the laser and photonics industry, has unveiled the Chameleon Discovery LX, an exciting new addition to its esteemed Chameleon Discovery product line. This revolutionary femtosecond laser is specifically designed for researchers engaged in nonlinear microscopy and...

Continue Reading
Neuronetics Shows Strong Revenue Growth Amid CEO Transition

Updated Category News Views 134

Neuronetics Reports Impressive Q3 2025 Results Neuronetics, Inc., a leader in neurohealth therapies, has shared substantial financial achievements for the third quarter of 2025. The company reported total revenues of $37.3 million, marking an significant adjusted pro forma growth of 11% compared to the same quarter in the previous year. This success can largely be...

Continue Reading